Stocksigma LogoStocksigma Logo

Aequs Limited: CARE Ratings Issues Q2FY27 Issue Proceeds Monitoring Report

CARE Ratings confirmed no material deviations in fund utilisation for Aequs Limited’s ₹144.00 crore Pre-IPO and ₹670.00 crore IPO proceeds for the quarter

Aequs Limited: CARE Ratings Issues Q2FY27 Issue Proceeds Monitoring Report

Aequs Ltd · Others (Uncategorized) · 28 Oct 2026, 10:56 pm

Aequs Limited: CARE Ratings Issues Q2FY27 Issue Proceeds Monitoring Report CARE Ratings confirmed no material deviations in fund utilisation for Aequs Limited’s ₹144.00 crore Pre-IPO and ₹670.00 crore IPO proceeds for the quarter ended 30th Sep'26. Pre-IPO utilisation reached ₹138.85 crore with ₹5.15 crore unutilised, while IPO proceeds utilisation stood at ₹591.10 crore with ₹78.90 crore unutilised. The monitoring agency highlighted minor governance observations, including unapproved excess capex of ₹8.49 crore versus ₹8.11 crore budgeted, commingling of funds via subsidiary current accounts, and unutilised proceeds parked in subsidiary bank accounts.

Original exchange filing (PDF)

More announcements from Aequs Ltd

All Aequs Ltd announcements